Generated by All in One SEO v4.8.9, this is an llms.txt file, used by LLMs to index the site.

# Glenmark Pharmaceutical

## Sitemaps

- [XML Sitemap](https://glph-ca-2025.local/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [GLN-Apremilast](https://glph-ca-2025.local/gln-apremilast/)
- [GLN-Atovaquone Suspension](https://glph-ca-2025.local/gln-atovaquone-suspension/)
- [Atovaquone/Proguanil](https://glph-ca-2025.local/atovaquone-proguanil/)
- [GLN-Bilastine](https://glph-ca-2025.local/gln-bilastine/)
- [GLN-Dapagliflozin Tabs 5mg 3x10's](https://glph-ca-2025.local/gln-dapagliflozin-tabs-5mg-3x10s/)
- [GLN-Dapagliflozin Tabs 10mg 3x10's](https://glph-ca-2025.local/gln-dapagliflozin-tabs-10mg-3x10s/)
- [GLN-Dapagliflozin Tabs 5mg 90's](https://glph-ca-2025.local/gln-dapagliflozin-tabs-5mg-90s/)
- [GLN-Dapagliflozin Tabs 10mg 90's](https://glph-ca-2025.local/gln-dapagliflozin-tabs-10mg-90s/)
- [Drospirenone and Ethinyl Estradiol](https://glph-ca-2025.local/drospirenone-and-ethinyl-estradiol/)
- [Gabapentin](https://glph-ca-2025.local/gabapentin/)
- [Maeve](https://glph-ca-2025.local/maeve/)
- [Olmesartan](https://glph-ca-2025.local/olmesartan/)
- [Olmesartan HCTZ](https://glph-ca-2025.local/olmesartan-hctz/)
- [GLN-Posaconazole](https://glph-ca-2025.local/gln-posaconazole/)
- [Stramucin](https://glph-ca-2025.local/stramucin/)
- [GLN-Topiramate](https://glph-ca-2025.local/gln-topiramate/)
- [Tri-Jordyna 21](https://glph-ca-2025.local/tri-jordyna-21/)
- [Tri-Jordyna 28](https://glph-ca-2025.local/tri-jordyna-28/)
- [Ursodiol](https://glph-ca-2025.local/ursodiol/)

## Pages

- [Home](https://glph-ca-2025.local/)
- [Generic Product Pricing List](https://glph-ca-2025.local/generic-product-pricing/)
- [Executive Leadership](https://glph-ca-2025.local/executive-leadership/) - Our management team consists of leaders in research, development, and commercialization that are focused on improving the lives of individuals.
- [Glenmark Code of Conduct](https://glph-ca-2025.local/about-us/glenmark-code-of-conduct/)
- [impetigoassessmenttool](https://glph-ca-2025.local/impetigoassessmenttool/)
- [Report Adverse Events](https://glph-ca-2025.local/report-adverse-events/)
- [Report Adverse Events](https://glph-ca-2025.local/patients/report-adverse-events-old/)
- [Patient Support Program](https://glph-ca-2025.local/healthcare-professionals-2/healthcare-professionals/)
- [Patient Support Program - Apremilast](https://glph-ca-2025.local/healthcare-professionals-2/patient-support-program/)
- [Glenmark Fournit des Comprimés de Colesevelam Hydrochloride 625 mg Malgré la Pénurie](https://glph-ca-2025.local/colesevelam-hydrochloride-625-mg-lettre/)
- [Glenmark Provides Colesevelam Hydrochloride 625 mg Tablets Despite Shortage](https://glph-ca-2025.local/colesevelam-hydrochloride-625-mg-letter/)
- [Glenmark Presence](https://glph-ca-2025.local/glenmark-presence/)
- [About Generic Drugs](https://glph-ca-2025.local/about-generic-drugs/)
- [Contact Us](https://glph-ca-2025.local/contact-us/) - Contact for the New Jersey and North Carolina Glenmark US offices and the Glenmark Canada office here.
- [Operations](https://glph-ca-2025.local/operations/) - Glenmark has manufacturing facilities in New Jersey and North Carolina where Good Manufacturing Practices (GMP) applied to ensure quality and safety.
- [Our Fundamentals](https://glph-ca-2025.local/about-us/our-fundamentals/) - Glenmark believes in diverse perspectives and functions for innovation, revolving around the core values of achievement, respect, and knowledge.
- [Our Story](https://glph-ca-2025.local/about-us/our-story/) - In 40 years, Glenmark has transformed into a global pharmaceutical company. Learn about our story from when we were founded in 1977.
- [Who We Are](https://glph-ca-2025.local/about-us/who-we-are/) - We are a global pharmaceutical company focused on solving serious medical problems for our patients, our people, and our communities. glenmark north america division, global pharmaceutical company
- [Healthcare Professionals](https://glph-ca-2025.local/healthcare-professionals-2/)
- [La crescente celebrità dei casinò online ha provocato miglioricasinoonlineaams.com](https://glph-ca-2025.local/la-crescente-celebrita-dei-casino-online-ha-provocato-miglioricasinoonlineaams-com/) - Il miglior locale di gioco d'azzardo è uno spazio in cui le persone si muovono in un "gioco d'azzardo", in alcune varianti con un po' di abilità, e in altre sulla pura fortuna. Negli ultimi anni, i casinò online sono diventati sempre più noti e hanno ampiamente sostituito i casinò classici. Pertanto, la necessità di
- [auto login](https://glph-ca-2025.local/auto-login/)
- [Privacy Policy](https://glph-ca-2025.local/privacy-policy/) - Glenmark may collect one or more types of personal data if you submit such data to Glenmark via their websites, learn more in the Glenmark Privacy Policy.
- [Terms Of Use](https://glph-ca-2025.local/terms-of-use/)
- [Generic Products](https://glph-ca-2025.local/products/generic-products/)
- [Stramucin](https://glph-ca-2025.local/products/branded-products/stramucin/)
- [Branded Products](https://glph-ca-2025.local/products/branded-products/)
- [Stramucin](https://glph-ca-2025.local/patients/stramucin/)
- [Patient Enrolment and Consent Form (French)](https://glph-ca-2025.local/patient-enrolment-and-consent-form-fr/)
- [Patient Enrolment and Consent Form](https://glph-ca-2025.local/patient-enrolment-and-consent-form/)
- [Site Map](https://glph-ca-2025.local/site-map/)
- [Global redirect](https://glph-ca-2025.local/global-redirect/)
- [Products](https://glph-ca-2025.local/products/)
- [Patients](https://glph-ca-2025.local/patients/) - Learn more about generic drugs, FDA standards, and how to report safety information or an adverse event.
- [About Us](https://glph-ca-2025.local/about-us/)

## Publications

- [Rapid Nasal Symptom Onset Of Action And Ocular Symptom Relief With Olopatadine/Mometasone Combination Nasal Spray In Patients With Seasonal Allergic Rhinitis: A Pooled Analysis](https://glph-ca-2025.local/publication/rapid-nasal-symptom-onset-of-action-and-ocular-symptom-relief-with-olopatadine-mometasone-combination-nasal-spray-in-patients-with-seasonal-allergic-rhinitis-a-pooled-analysis-2/)
- [Olopatadine/Mometasone Combination Nasal Spray for the Treatment of Seasonal Allergic Rhinitis: A Pooled Analysis of Efficacy and Safety](https://glph-ca-2025.local/publication/olopatadine-mometasone-combination-nasal-spray-for-the-treatment-of-seasonal-allergic-rhinitis-a-pooled-analysis-of-efficacy-and-safety-2/)
- [Rapid Nasal Symptom Onset Of Action And Ocular Symptom Relief With Olopatadine/Mometasone Combination Nasal Spray In Patients With Seasonal Allergic Rhinitis: A Pooled Analysis](https://glph-ca-2025.local/publication/rapid-nasal-symptom-onset-of-action-and-ocular-symptom-relief-with-olopatadine-mometasone-combination-nasal-spray-in-patients-with-seasonal-allergic-rhinitis-a-pooled-analysis/)
- [Evidence For Activity Of GBR 830 (Anti-OX40) In Extrinsic And Intrinsic Atopic Dermatitis (AD) In A Phase 2A Study](https://glph-ca-2025.local/publication/evidence-for-activity-of-gbr-830-anti-ox40-in-extrinsic-and-intrinsic-atopic-dermatitis-ad-in-a-phase-2a-study-2/)
- [Evidence For Activity Of GBR 830 (Anti-OX40) In Extrinsic And Intrinsic Atopic Dermatitis (AD) In A Phase 2A Study](https://glph-ca-2025.local/publication/evidence-for-activity-of-gbr-830-anti-ox40-in-extrinsic-and-intrinsic-atopic-dermatitis-ad-in-a-phase-2a-study/)
- [GBR 830, An Anti-OX40, Improves Skin Gene Signatures And Clinical Scores In Patients  With Atopic Dermatitis](https://glph-ca-2025.local/publication/gbr-830-an-anti-ox40-improves-skin-gene-signatures-and-clinical-scores-in-patients-with-atopic-dermatitis/)
- [Quality Of Life Improvements Following Treatment With Olopatadine/Mometasone Combination Nasal Spray For The Treatment Of Seasonal Allergic Rhinitis: A Pooled Analysis](https://glph-ca-2025.local/publication/quality-of-life-improvements-following-treatment-with-olopatadine-mometasome-combination-nasal-spray-in-patients-with-seasonal-allegeric-rhinitis-a-pooled-analysis/)
- [Clinical Pharmokinetics And Immunogenicity Of GBR 830, A First-In-Class Humanized Monoclonal Antibody Inhibiting OX40 To Treat Atopic Dermatitis](https://glph-ca-2025.local/publication/clinical-pharmokinetics-and-immunogenicity-of-gbr-830-a-first-in-class-humanized-monoclonal-antibody-inhibiting-ox40-to-treat-atopic-dermatitis/)
- [GBR 830 Induces Progressive And Sustained Improvements In Atopic Dermatitis Skin Biomarkers And Clinical Parameters](https://glph-ca-2025.local/publication/gbr-830-induces-progressive-and-sustained-improvements-in-atopic-dermatitis-skin-biomarkers-and-clinical-parameters/)
- [Olopatadine/Mometasone Combination Nasal Spray For The Treatment Of Seasonal Allergic Rhinitis: A Pooled Analysis Of Efficacy And Safety](https://glph-ca-2025.local/publication/olopatadine-mometasone-combination-nasal-spray-for-the-treatment-of-seasonal-allergic-rhinitis-a-pooled-analysis-of-efficacy-and-safety/)
- [Morning And Evening Nasal Symptom Improvement With Olopatadine/Mometasone Combination Nasal Spray In Patients With Seasonal Allergic Rhinitis](https://glph-ca-2025.local/publication/morning-and-evening-nasal-symptom-improvement-with-olopatadine-mometasone-combination-nasal-spray-in-patients-with-seasonal-allergic-rhinitis/)
- [A Phase 1 Study Of The Bispecific Antibody T Cell Engager GBR 1302 In Subjects With HER2-Positive Cancers](https://glph-ca-2025.local/publication/a-phase-1-study-of-the-bispecific-antibody-t-cell-engager-gbr-1302-in-subjects-with-her2-positive-cancers/)
- [A Phase 1 Study Of GBR 1302 In Subjects With HER2-Positive Cancers](https://glph-ca-2025.local/publication/a-phase-1-study-of-gbr-1302-in-subjects-with-her2-positive-cancers/)
- [Preliminary Biomarker And Pharmacodynamic Data From A Phase 1 Study Of Single-Agent Bispecific Antibody T Cell Engager GBR 1302 In Subjects With HER2‐Positive Cancers](https://glph-ca-2025.local/publication/preliminary-biomarker-and-pharmacodynamic-data-from-a-phase-1-study-of-single-agent-bispecific-antibody-t-cell-engager-gbr-1302-in-subjects-with-her2‐positive-cancers/)
- [Efficacy And Safety Of Olopatadine/Mometasone Combination Nasal Spray For The Treatment Of Seasonal Allergic Rhinitis](https://glph-ca-2025.local/publication/efficacy-and-safety-of-olopatadine-mometasone-combination-nasal-spray-for-the-treatment-of-seasonal-allergic-rhinitis-4/)
- [Long-Term Safety And Efficacy Of Olopatadine/Mometasone Combination Nasal Spray In Patients With Perennial Allergic Rhinitis](https://glph-ca-2025.local/publication/long-term-safety-and-efficacy-of-olopatadine-mometasone-combination-nasal-spray-in-patients-with-perennial-allergic-rhinitis/)
- [Seasonal Allergic Rhinitis Nasal Symptoms And Quality Of Life With Olopatadine/Mometasone Combination Nasal Spray](https://glph-ca-2025.local/publication/seasonal-allergic-rhinitis-nasal-symptoms-and-quality-of-life-with-olopatadine-mometasone-combination-nasal-spray/)
- [Olopatadine/Mometasone Combination Nasal Spray Effectively Improves Seasonal Allergic Rhinitis Nasal Symptoms And Quality Of Life](https://glph-ca-2025.local/publication/olopatadine-mometasone-combination-nasal-spray-effectively-improves-seasonal-allergic-rhinitis-nasal-symptoms-and-quality-of-life/)
- [Preliminary Pharmacokinetic Results From a Phase 1 Study of GBR 1302 in Patients With HER2-Positive Cancers](https://glph-ca-2025.local/publication/preliminary-pharmacokinetic-results-from-a-phase-1-study-of-gbr-1302-in-patients-with-her2-positive-cancers/)
- [Olopatadine/Mometasone Combination Nasal Spray Improves Seasonal Allergic Rhinitis Symptoms In A 
Ragweed Environmental Exposure Chamber](https://glph-ca-2025.local/publication/olopatadine-mometasone-combination-nasal-spray-improves-seasonal-allergic-rhinitis-symptoms-in-a
ragweed-environmental-exposure-chamber/)
- [Pharmacokinetics Of Olopatadine Administered As GSP301 Nasal Spray Versus Olopatadine Monotherapy](https://glph-ca-2025.local/publication/pharmacokinetics-of-olopatadine-administered-as-gsp301-nasal-spray-versus-olopatadine-monotherapy/)
- [Pharmacokinetics Of Mometasone Furoate Administered As GSP301 Nasal Spray Versus Mometasone Monotherapy](https://glph-ca-2025.local/publication/pharmacokinetics-of-mometasone-furoate-administered-as-gsp301-nasal-spray-versus-mometasone-monotherapy/)
- [Targeting OX40 With GBR 830, An OX40 Antagonist, Inhibits T Cell-Mediated Pathological Responses](https://glph-ca-2025.local/publication/targeting-ox40-with-gbr-830-an-ox40-antagonist-inhibits-t-cell-mediated-pathological-responses/)
- [Clinical Pharmacokinetics And Immunogenicity Of GBR 830, A First-In-Class Humanized Monoclonal Antibody Inhibiting OX40 To Treat Atopic Dermatitis](https://glph-ca-2025.local/publication/clinical-pharmacokinetics-and-immunogenicity-of-gbr-830-a-first-in-class-humanized-monoclonal-antibody-inhibiting-ox40-to-treat-atopic-dermatitis/)
- [GBR 830: An OX40 Antagonist Antibody With A Favorable Toxicity Profile In Non-Human Primates](https://glph-ca-2025.local/publication/gbr-830-an-ox40-antagonist-antibody-with-a-favorable-toxicity-profile-in-non-human-primates/)
- [GBR 1302: Effect Of CD3-HER2, A Bispecific T Cell Engager Antibody, In Trastuzumab-Resistant Cancers](https://glph-ca-2025.local/publication/gbr-1302-effect-of-cd3-her2-a-bispecific-t-cell-engager-antibody/)
- [Results From A Randomized, Double-Blind, Placebo‐Controlled, Exploratory, Multicenter Study Of GBR 830 In Adult Patients With Moderate-To-Severe Atopic Dermatitis](https://glph-ca-2025.local/publication/results-from-a-randomized-double-blind-placebo‐controlled-exploratory-multicenter-study-of-gbr-830-in-adult-patients-with-moderate-to-severe-atopic-dermatitis/)
- [Results From A Phase 2a Randomized, Double-Blind, Placebo-Controlled, Exploratory, Multicenter Study Of GBR 830 In Adult Patients With Moderate-To-Severe Atopic Dermatitis](https://glph-ca-2025.local/publication/results-from-a-phase-2a-randomized-double-blind-placebo-controlled-exploratory-multicenter-study-of-gbr-830-in-adult-patients-with-moderate-to-severe-atopic-dermatitis/)
- [Phase 1, Multicenter, Open-Label Study Of Single-Agent Bispecific Antibody T Cell Engager GBR 1342 In Relapsed/Refractory Multiple Myeloma](https://glph-ca-2025.local/publication/phase-1-multicenter-open-label-study-of-single-agent-bispecific-antibody-t-cell-engager-gbr-1342-in-relapsed-refractory-multiple-myeloma-2/)
- [Phase 1, Multicenter, Open-Label Study Of Single-Agent Bispecific Antibody T Cell Engager GBR 1342 In Relapsed/Refractory Multiple Myeloma](https://glph-ca-2025.local/publication/phase-1-multicenter-open-label-study-of-single-agent-bispecific-antibody-t-cell-engager-gbr-1342-in-relapsed-refractory-multiple-myeloma/)
- [Pharmacokinetics of intranasal mometasone in the fixed-dose combination GSP301 versus two monotherapy intranasal mometasone formulations](https://glph-ca-2025.local/publication/pharmacokinetics-of-intranasal-mometasone-in-the-fixed-dose-combination-gsp301-versus-two-monotherapy-intranasal-mometasone-formulations/)
- [Pharmacokinetics of intranasal olopatadine in the fixed-dose combination GSP301 versus two monotherapy intranasal olopatadine formulations](https://glph-ca-2025.local/publication/pharmacokinetics-of-intranasal-olopatadine-in-the-fixed-dose-combination-gsp301-versus-two-monotherapy-intranasal-olopatadine-formulations/)
- [Rapid Onset Of Action On Nasal Symptoms And Ocular Symptom Relief With Olopatadine/Mometasone Combination Nasal Spray In A Ragweed Environmental Exposure Chamber](https://glph-ca-2025.local/publication/rapid-onset-of-action-on-nasal-symptoms-and-ocular-symptom-relief-with-olopatadine-mometasone-combination-nasal-spray-in-a-ragweed-environmental-exposure-chamber/)
- [Efficacy And Safety Of Olopatadine/Mometasone Combination Nasal Spray For The Treatment Of Seasonal Allergic Rhinitis](https://glph-ca-2025.local/publication/efficacy-and-safety-of-olopatadine-mometasone-combination-nasal-spray-for-the-treatment-of-seasonal-allergic-rhinitis-3/)
- [Olopatadine/Mometasone Combination Nasal Spray Improves Nasal Symptoms In Seasonal Allergic Rhinitis Patients](https://glph-ca-2025.local/publication/olopatadine-mometasone-combination-nasal-spray-improves-nasal-symptoms-in-seasonal-allergic-rhinitis-patients/)
- [Efficacy And Safety Of Olopatadine/Mometasone Combination Nasal Spray For The Treatment Of Seasonal Allergic Rhinitis](https://glph-ca-2025.local/publication/efficacy-and-safety-of-olopatadine-mometasone-combination-nasal-spray-for-the-treatment-of-seasonal-allergic-rhinitis/)
- [Rapid Onset Of Action And Improvement Of Nasal And Ocular Symptoms With Olopatadine/Mometasone Combination Nasal Spray In Patients With Seasonal Allergic Rhinitis](https://glph-ca-2025.local/publication/rapid-onset-of-action-and-improvement-of-nasal-and-ocular-symptoms-with-olopatadine-mometasone-combination-nasal-spray-in-patients-with-seasonal-allergic-rhinitis-2/)
- [Olopatadine/Mometasone Combination Nasal Spray Provides Rapid Onset Of Action And Improves Ocular Symptoms In Patients With Seasonal Allergic Rhinitis](https://glph-ca-2025.local/publication/olopatadine-mometasone-combination-nasal-spray-provides-rapid-onset-of-action-and-improves-ocular-symptoms-in-patients-with-seasonal-allergic-rhinitis/)
- [Rapid Onset Of Action And Improvement Of Nasal And Ocular Symptoms With Olopatadine/Mometasone Combination Nasal Spray In Patients With Seasonal Allergic Rhinitis](https://glph-ca-2025.local/publication/rapid-onset-of-action-and-improvement-of-nasal-and-ocular-symptoms-with-olopatadine-mometasone-combination-nasal-spray-in-patients-with-seasonal-allergic-rhinitis/)
- [Rapid Onset Of Action On Nasal Symptoms And Ocular Symptom Improvement With Olopatadine/Mometasone Combination Nasal Spray In Patients With Seasonal Allergic Rhinitis](https://glph-ca-2025.local/publication/rapid-onset-of-action-on-nasal-symptoms-and-ocular-symptom-improvement-with-olopatadine-mometasone-combination-nasal-spray-in-patients-with-seasonal-allergic-rhinitis/)
- [Efficacy And Safety Of Olopatadine/Mometasone Combination Nasal Spray In Patients With Seasonal Allergic Rhinitis](https://glph-ca-2025.local/publication/efficacy-and-safety-of-olopatadine-mometasone-combination-nasal-spray-in-patients-with-seasonal-allergic-rhinitis/)
- [Efficacy And Safety Of Once-Daily And Twice-Daily Olopatadine/Mometasone Nasal Spray Treatment In Seasonal Allergic Rhinitis](https://glph-ca-2025.local/publication/efficacy-and-safety-of-once-daily-and-twice-daily-olopatadine-mometasone-nasal-spray-treatment-in-seasonal-allergic-rhinitis/)
- [GBR 830 Induces Progressive And Sustained Improvements In Atopic Dermatitis Skin Biomarkers And Clinical Parameters](https://glph-ca-2025.local/publication/gbr-830-induces-progressive-and-sustained-improvements-in-atopic-dermatitis-skin-biomarkers-and-clinical-parameters-2/)

## Pricelist

- [Ursodiol](https://glph-ca-2025.local/pricelist/ursodiol/)
- [Stramucin](https://glph-ca-2025.local/pricelist/stramucin/)
- [GLN-Topiramate](https://glph-ca-2025.local/pricelist/gln-topiramate/)
- [Olmesartan HCTZ](https://glph-ca-2025.local/pricelist/olmesartan-hctz/)
- [Olmesartan](https://glph-ca-2025.local/pricelist/olmesartan/)
- [GLN-Posaconazole](https://glph-ca-2025.local/pricelist/gln-posaconazole/)
- [Tri-Jordyna 21](https://glph-ca-2025.local/pricelist/tri-jordyna-21/)
- [Tri-Jordyna 28](https://glph-ca-2025.local/pricelist/tri-jordyna-28/)
- [Gabapentin](https://glph-ca-2025.local/pricelist/gabapentin/)
- [Drospirenone and Ethinyl Estradiol](https://glph-ca-2025.local/pricelist/drospirenone-and-ethinyl-estradiol/)
- [GLN-Bilastine](https://glph-ca-2025.local/pricelist/gln-bilastine/)
- [Atovaquone/Proguanil](https://glph-ca-2025.local/pricelist/atovaquone-proguanil/)
- [Product](https://glph-ca-2025.local/pricelist/product/)
- [GLN-Apremilast](https://glph-ca-2025.local/pricelist/gln-apremilast/)
- [GLN-Atovaquone Suspension](https://glph-ca-2025.local/pricelist/gln-atovaquone-suspension/)
- [GLN-Dapagliflozin Tabs 5mg 3x10's](https://glph-ca-2025.local/pricelist/gln-dapagliflozin-tabs-5mg-3x10s/)
- [GLN-Dapagliflozin Tabs 10mg 3x10's](https://glph-ca-2025.local/pricelist/gln-dapagliflozin-tabs-10mg-3x10s/)
- [GLN-Dapagliflozin Tabs 5mg 90's](https://glph-ca-2025.local/pricelist/gln-dapagliflozin-tabs-5mg-90s/)
- [GLN-Dapagliflozin Tabs 10mg 90's](https://glph-ca-2025.local/pricelist/gln-dapagliflozin-tabs-10mg-90s/)
- [Maeve](https://glph-ca-2025.local/pricelist/maeve/)

## Categories

- [Generic Products](https://glph-ca-2025.local/category/product-catalog/)
- [Oncology](https://glph-ca-2025.local/category/oncology/)
- [Dermatology](https://glph-ca-2025.local/category/dermatology/)
- [Respiratory](https://glph-ca-2025.local/category/respiratory/)

## Tags

- [GBR 1302](https://glph-ca-2025.local/tag/gbr-1302/)
- [GBR 830](https://glph-ca-2025.local/tag/gbr-830/)
- [GBR 1342](https://glph-ca-2025.local/tag/gbr-1342/)
- [GSP 301](https://glph-ca-2025.local/tag/gsp-301/)